Literature DB >> 31748808

Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis.

Taís M Campos1,2, Fernanda O Novais3, Maíra Saldanha4, Rúbia Costa2, Morgana Lordelo5, Daniela Celestino2, Camilla Sampaio1,2, Natália Tavares5, Sérgio Arruda4, Paulo Machado2,6, Cláudia Brodskyn5, Phillip Scott3, Edgar M Carvalho1,2,6, Lucas P Carvalho1,2,6.   

Abstract

BACKGROUND: Skin lesions from patients infected with Leishmania braziliensis has been associated with inflammation induced by cytotoxic CD8+ T cells. In addition, CD8+ T cell-mediated cytotoxicity has not been linked to parasite killing. Meanwhile, the cytotoxic role played by natural killer (NK) cells in cutaneous leishmaniasis (CL) remains poorly understood.
METHODS: In this study, we observed higher frequencies of NK cells in the peripheral blood of CL patients compared with healthy subjects, and that NK cells expressed more interferon-γ, tumor necrosis factor (TNF), granzyme B, and perforin than CD8+ T cells.
RESULTS: We also found that most of the cytotoxic activity in CL lesions was triggered by NK cells, and that the high levels of granzyme B produced in CL lesions was associated with larger lesion size. Furthermore, an in vitro blockade of granzyme B was observed to decrease TNF production. CONCCLUSIONS: Our data, taken together, suggest an important role by NK cells in inducing inflammation in CL, thereby contributing to disease immunopathology.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD8+ T cells; NK cells; cutaneous leishmaniasis; cytotoxic activity; granzyme B

Mesh:

Substances:

Year:  2020        PMID: 31748808      PMCID: PMC7050991          DOI: 10.1093/infdis/jiz538

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

1.  Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity.

Authors:  Chittappen K Prajeeth; Simone Haeberlein; Heidi Sebald; Ulrike Schleicher; Christian Bogdan
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.

Authors:  Matthieu Allez; Vannary Tieng; Atsushi Nakazawa; Xavier Treton; Vincent Pacault; Nicolas Dulphy; Sophie Caillat-Zucman; Pascale Paul; Jean-Marc Gornet; Corinne Douay; Sophie Ravet; Ryad Tamouza; Dominique Charron; Marc Lémann; Lloyd Mayer; Antoine Toubert
Journal:  Gastroenterology       Date:  2007-03-16       Impact factor: 22.682

3.  Total lymphocyte CD8 expression is not a reliable marker of cytotoxic T-cell populations in human peripheral blood following an acute bout of high-intensity exercise.

Authors:  John P Campbell; Keith Guy; Cormac Cosgrove; Geraint D Florida-James; Richard J Simpson
Journal:  Brain Behav Immun       Date:  2007-10-18       Impact factor: 7.217

Review 4.  The biology of human natural killer-cell subsets.

Authors:  M A Cooper; T A Fehniger; M A Caligiuri
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

5.  Intermediate monocytes contribute to pathologic immune response in Leishmania braziliensis infections.

Authors:  Sara Passos; Lucas P Carvalho; Rúbia S Costa; Taís M Campos; Fernanda O Novais; Andréa Magalhães; Paulo R L Machado; Daniel Beiting; David Mosser; Edgar M Carvalho; Phillip Scott
Journal:  J Infect Dis       Date:  2014-08-19       Impact factor: 5.226

Review 6.  Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules.

Authors:  Geneviève de Saint Basile; Gaël Ménasché; Alain Fischer
Journal:  Nat Rev Immunol       Date:  2010-07-16       Impact factor: 53.106

Review 7.  Granzyme B in injury, inflammation, and repair.

Authors:  Paul R Hiebert; David J Granville
Journal:  Trends Mol Med       Date:  2012-10-22       Impact factor: 11.951

8.  Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study.

Authors:  Aline C Muniz; Olívia Bacellar; Ednaldo Lima Lago; Augusto M Carvalho; Pedro Paulo Carneiro; Luiz Henrique Guimarães; Paulo N Rocha; Lucas P Carvalho; Marshall Glesby; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2016-05-18       Impact factor: 5.226

9.  CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.

Authors:  Fernanda O Novais; Augusto M Carvalho; Megan L Clark; Lucas P Carvalho; Daniel P Beiting; Igor E Brodsky; Edgar M Carvalho; Phillip Scott
Journal:  PLoS Pathog       Date:  2017-02-13       Impact factor: 6.823

10.  CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis.

Authors:  Claire da Silva Santos; Viviane Boaventura; Cristina Ribeiro Cardoso; Natalia Tavares; Morgana J Lordelo; Almério Noronha; Jackson Costa; Valéria M Borges; Camila I de Oliveira; Johan Van Weyenbergh; Aldina Barral; Manoel Barral-Netto; Cláudia Ida Brodskyn
Journal:  J Invest Dermatol       Date:  2013-01-15       Impact factor: 8.551

View more
  13 in total

1.  Compartmentalized cytotoxic immune response leads to distinct pathogenic roles of natural killer and senescent CD8+ T cells in human cutaneous leishmaniasis.

Authors:  Luciana Polaco Covre; Oliver Patrick Devine; Renan Garcia de Moura; Milica Vukmanovic-Stejic; Reynaldo Dietze; Rodrigo Ribeiro-Rodrigues; Herbert Leonel de Matos Guedes; Raphael Lubiana Zanotti; Aloisio Falqueto; Arne N Akbar; Daniel Claudio Oliveira Gomes
Journal:  Immunology       Date:  2020-01-26       Impact factor: 7.397

2.  Transcriptomic landscape of skin lesions in cutaneous leishmaniasis reveals a strong CD8+ T cell immunosenescence signature linked to immunopathology.

Authors:  Carlos Henrique Fantecelle; Luciana Polaco Covre; Renan Garcia de Moura; Herbert Leonel de Matos Guedes; Camila Farias Amorim; Phillip Scott; David Mosser; Aloisio Falqueto; Arne N Akbar; Daniel Claudio Oliveira Gomes
Journal:  Immunology       Date:  2021-09-01       Impact factor: 7.397

3.  The Leishmania antigen-specific pro-inflammatory response in cutaneous leishmaniasis is linked to disease progression but not to the therapeutic failure of pentavalent antimonials.

Authors:  Mônica Franca; Luiz H Guimarães; Maurício T Nascimento; Paulo N Rocha; Lucas P Carvalho
Journal:  Microbes Infect       Date:  2021-07-21       Impact factor: 2.700

4.  Previous History of American Tegumentary Leishmaniasis Alters Susceptibility and Immune Response Against Schistosoma mansoni Infection in Humans.

Authors:  Guilherme Silva Miranda; Samira Diniz Resende; Diogo Tavares Cardoso; Genil Mororó Araújo Camelo; Jeferson Kelvin Alves Oliveira Silva; Vanessa Normandio de Castro; Stefan Michael Geiger; Mariângela Carneiro; Deborah Negrão-Corrêa
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

5.  Localized skin inflammation during cutaneous leishmaniasis drives a chronic, systemic IFN-γ signature.

Authors:  Camila Farias Amorim; Fernanda O Novais; Ba T Nguyen; Mauricio T Nascimento; Jamile Lago; Alexsandro S Lago; Lucas P Carvalho; Daniel P Beiting; Phillip Scott
Journal:  PLoS Negl Trop Dis       Date:  2021-04-01

Review 6.  Host-Directed Therapies for Cutaneous Leishmaniasis.

Authors:  Fernanda O Novais; Camila Farias Amorim; Phillip Scott
Journal:  Front Immunol       Date:  2021-03-26       Impact factor: 7.561

Review 7.  Unraveling the Role of Immune Checkpoints in Leishmaniasis.

Authors:  Rafael de Freitas E Silva; Esther von Stebut
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

8.  Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against Leishmania mexicana Infection.

Authors:  Bernard Ong'ondo Osero; Zama Cele; Raphael Taiwo Aruleba; Rebeng A Maine; Mumin Ozturk; Manfred B Lutz; Frank Brombacher; Ramona Hurdayal
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

9.  Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis.

Authors:  Fábio Peixoto; Maurício T Nascimento; Rúbia Costa; Juliana Silva; Gaby Renard; Luiz Henrique Guimarães; Gerson Penna; Manoel Barral-Netto; Lucas P Carvalho; Paulo R L Machado; Edgar M Carvalho
Journal:  J Immunol Res       Date:  2020-08-06       Impact factor: 4.818

10.  Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4+ T Effector and Regulatory T Cells in Cutaneous Leishmaniasis.

Authors:  Rafael de Freitas E Silva; Rosa Isela Gálvez; Valéria Rego Alves Pereira; Maria Edileuza Felinto de Brito; Siew Ling Choy; Hannelore Lotter; Lidia Bosurgi; Thomas Jacobs
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.